ADA Calls for Standardized Safety Review of Insulin Pumps

All makers of insulin pumps should follow a standardized review and categorization procedure for analyzing problems with their products, the ADA and the European Association for the Study of Diabetes wrote in a joint statement published in the journal Diabetes Care. Although adverse event reports submitted by manufacturers to the FDA are publicly available, it is difficult to access that data because each manufacturer uses its own process, the groups said. — ADA press release